Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Westley C"'
Publikováno v:
ACS Omega, Vol 9, Iss 23, Pp 25390-25394 (2024)
Externí odkaz:
https://doaj.org/article/eb43bbd05380468b976009cc8fa92124
Autor:
Giovanni A. Ramirez, Tesfay T. Tesfatsion, Maite L. Docampo-Palacios, Ivan Cruces, Adam J. Hellmann, Alex Okhovat, Monica K. Pittiglio, Kyle P. Ray, Westley Cruces
Publikováno v:
ACS Omega, Vol 9, Iss 11, Pp 13191-13199 (2024)
Externí odkaz:
https://doaj.org/article/fc4565e6f2454c388fbca055050009b5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Westley, C, Fisk, H, Xu, Y, Hollywood, KA, Carnell, AJ, Micklefield, J, Turner, NJ, Goodacre, R
Publikováno v:
Chemistry: A European Journal
For enzyme‐catalysed biotransformations, continuous in situ detection methods minimise the need for sample manipulation, ultimately leading to more accurate real‐time kinetic determinations of substrate(s) and product(s). We have established for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::543b4e71d5f0af67f80e3538d83d78b2
http://livrepository.liverpool.ac.uk/3006725/1/UVRR-ChemEuroJ.docx
http://livrepository.liverpool.ac.uk/3006725/1/UVRR-ChemEuroJ.docx
Publikováno v:
Journal of Molluscan Studies. May2010, Vol. 76 Issue 2, p186-195. 10p. 2 Color Photographs, 5 Black and White Photographs, 1 Chart.
Publikováno v:
Journal of Nuclear Medicine Technology. 39:190-194
The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, specifically for Hodgkin disease and aggressive types of non-Hodgkin lymphoma. PET and PET/CT are used to initially stage lymphoma, restage disease, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b938b6902872f5e0c9ad2ffe8c22911
https://doi.org/10.2967/jnmt.110.082982
https://doi.org/10.2967/jnmt.110.082982
Autor:
Maite L. Docampo-Palacios, Giovanni A. Ramirez, Tesfay T. Tesfatsion, Alex Okhovat, Monica Pittiglio, Kyle P. Ray, Westley Cruces
Publikováno v:
Molecules, Vol 28, Iss 17, p 6434 (2023)
Natural and non-natural hexahydrocannabinols (HHC) were first described in 1940 by Adam and in late 2021 arose on the drug market in the United States and in some European countries. A background on the discovery, synthesis, and pharmacology studies
Externí odkaz:
https://doaj.org/article/1aa1c14d813044e59684dd37d20a721f